Paul Verbraeken
Analyst-Equity bei Research Partners AG
Profil
Mr. Paul Verbraeken is a Senior Analyst at Research Partners AG.
He has more than 25 years of experience as an IR Manager, including as Head of IR at a healthcare company listed on SIX Swiss Exchanges, and as an equity analyst at a number of European investment banks.
He holds a degree in Auditing from The Hague University of Applied Sciences (Netherlands) and has received further training in investor relations from the Amsterdam Institute of Finance/INSEAD and the Investor Relations Society, London.
Aktive Positionen von Paul Verbraeken
| Unternehmen | Position | Beginn |
|---|---|---|
Research Partners AG
 Research Partners AG Investment ManagersFinance Research Partners AG provides investment research. The private company is based in Zurich, Switzerland. The Swiss company was founded in 2014 by Martin Coninx. Martin Coninx has been the CEO since 2014. | Analyst-Equity | 01.10.2018 |
Ehemalige bekannte Positionen von Paul Verbraeken
| Unternehmen | Position | Ende |
|---|---|---|
Arpida AG
 Arpida AG BiotechnologyHealth Technology Arpida AG develops and discovers drugs for microbial resistance. The company's products include intravenous iclaprim, and antibiotics. The antibiotics provides resistance towards the methicillin-resistant Staphylococcus aureus (MRSA). The company also discovers an oral formulation of iclaprim. The company was founded by Dr. Dieter Gillessen, Bernhard Erni and Dr. Ivan Kompis in July 1997 and is headquartered in Reinach, Switzerland. | Public Communications Contact | 14.12.2009 |
HSBC Bank Plc (Broker)
 HSBC Bank Plc (Broker) Investment Banks/BrokersFinance HSBC Bank Plc (Broker) (HSBC Bank-Broker) is the broker/dealer division of HSBC Bank Plc, which is owned by HSBC Holdings Plc (LON: HSBA; NYSE: HSBC) in Great Britain. Headquartered in London, HSBC Bank-Broker was founded in 1880 and offers bespoke brokerage services across every major asset class for their corporate and institutional clients. | Analyst-Equity | 09.04.2002 |
| EVOLVA HOLDING SA | Investor Relations Kontakt | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| EVOLVA HOLDING SA | Consumer Non-Durables |
| Private Unternehmen | 3 |
|---|---|
Arpida AG
Arpida AG BiotechnologyHealth Technology Arpida AG develops and discovers drugs for microbial resistance. The company's products include intravenous iclaprim, and antibiotics. The antibiotics provides resistance towards the methicillin-resistant Staphylococcus aureus (MRSA). The company also discovers an oral formulation of iclaprim. The company was founded by Dr. Dieter Gillessen, Bernhard Erni and Dr. Ivan Kompis in July 1997 and is headquartered in Reinach, Switzerland. | Health Technology |
HSBC Bank Plc (Broker)
HSBC Bank Plc (Broker) Investment Banks/BrokersFinance HSBC Bank Plc (Broker) (HSBC Bank-Broker) is the broker/dealer division of HSBC Bank Plc, which is owned by HSBC Holdings Plc (LON: HSBA; NYSE: HSBC) in Great Britain. Headquartered in London, HSBC Bank-Broker was founded in 1880 and offers bespoke brokerage services across every major asset class for their corporate and institutional clients. | Finance |
Research Partners AG
Research Partners AG Investment ManagersFinance Research Partners AG provides investment research. The private company is based in Zurich, Switzerland. The Swiss company was founded in 2014 by Martin Coninx. Martin Coninx has been the CEO since 2014. | Finance |
